Project Grant R01DA064602
Award Date 7/1/26
Completion Date 5/31/31
Dollars Obligated $886K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $500,000 to The Trustees of The University of Pennsylvania under the Drug Use and Addiction Research Programs (CFDA 93.279) Project Grant mechanism, with an award date of May 18, 2026, and ultimate completion date of February 28, 2031. This project, "Advancing Multimodal AI/ML to Enhance HIV Clinical Care," develops novel artificial intelligence and machine learning (AI/ML) models that integrate multiple...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Pennsylvania $1.59 million on August 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a rigorous evaluation of Hospital-to-Housing (H2H), a medically supported transitional housing intervention for individuals experiencing homelessness with opioid use disorder (OUD) following hospitalization. The project, which extends through May 31, 2030, will assess...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $188,995 to the University of Pittsburgh on August 15, 2025, to support the "Prescribe to Prevent HIV" (P2PH) trial through July 31, 2028. This project grant funds the development and pilot testing of an implementation strategy bundle designed to expand access to two evidence-based harm reduction interventions—sterile injection...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded The Johns Hopkins University a $232,625 Project Grant effective September 15, 2025, through August 31, 2027. This research initiative examines co-infection patterns of HIV, hepatitis C, and sexually transmitted infections (syphilis, gonorrhea, and chlamydia) among people who inject drugs (PWID) in Cabell County, West Virginia, where an ongoing HIV...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $2.24 million Project Grant to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and deploy an innovative, community-informed modeling approach for HIV and Hepatitis C Virus (HCV) prevention resource allocation among people who use drugs (PWUD) in the United States. The project, titled "Nothing About Us Without Us: Integrating the Voices of...
- Summary of Federal Project Grant Award RTI International received a $613,917 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct an implementation science study aimed at improving HIV prevention and treatment for people who inject drugs (PWID) across the United States. The award, which commenced May 1, 2026, and concludes February 28, 2030, will deliver spatiotemporal modeling and analysis to estimate...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Miami's Office of Research Administration - School of Medicine Division a $109,652 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective August 19, 2026, through August 18, 2027, to conduct implementation research on comprehensive telehealth models for addressing HIV and substance use disorder among people who inject drugs (PWID). This research directly supports...
- Summary The National Institute on Drug Abuse (NIDA) awarded $2.31 million to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, through April 30, 2030. This Project Grant funds a hybrid Type I implementation trial titled "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," which addresses the intersecting epidemics of HIV and substance use...
- Federal Grant Award Summary The University of Pennsylvania received a $454,251 Project Grant awarded July 15, 2025, by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop innovative diagnostic and monitoring tools for opioid use disorder research. The project, extending through June 30, 2027, focuses on creating a device-free blood-based biomarker detection system called Released Markers of Activity (RMAs) to enable long-term...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Miami a $793,508 Project Grant effective March 1, 2026 through January 31, 2031 under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds STRIVES (Status-Neutral Tele-Health Concierge Intervention for People Who Use Drugs via Engagement Through Street Medicine), a telehealth-based, multicomponent care model designed to increase access to HIV prevention, testing, and treatment...